LSTM Home > LSTM Research > LSTM Online Archive

Conjugate pneumococcal vaccine in HIV-infected Ugandans and the effect of past receipt of polysaccharide vaccine

Miiro, G., Kayhty, H., Watera, C., Tolmie, Helen, Whitworth, J. A. G., Gilks, C.F. and French, Neil (2005) 'Conjugate pneumococcal vaccine in HIV-infected Ugandans and the effect of past receipt of polysaccharide vaccine'. Journal of Infectious Disease, Vol 192, Issue 10, pp. 1801-1805.

Full text not available from this repository.

Abstract

We investigated the immunogenicity of a 7-valent conjugate pneumococcal vaccine (CPV) in human immunodeficiency virus - infected Ugandan adults and measured the effect of past pneumococcal polysaccharide vaccine (PPV) receipt given as part of a controlled trial. Two doses of CPV, 4 weeks apart, were given to 54 past PPV recipients and 55 past placebo recipients (84% female; median CD4 cell count, 251 cells/mu L [range, 1 - 936 cells/mu L]). Postvaccination anticapsular immunoglobulin G (IgG) concentrations were directly correlated with CD4 cell count (P < .01 for all serotypes). There were significant increases in anticapsular IgG concentrations for all serotypes after the first dose (P < .01) and for all serotypes except 14 and 9V after the second dose. Past receipt of PPV did not affect vaccine response.

Item Type: Article
Subjects: QW Microbiology and Immunology > Immunotherapy and Hypersensitivity > QW 806 Vaccination
WC Communicable Diseases > Virus Diseases > Acquired Immunodeficiency Syndrome. HIV Infections > WC 503.5 Complications
WF Respiratory System > Tuberculosis > WF 200 Tuberculosis (General)
Digital Object Identifer (DOI): https://doi.org/10.1086/497144
Depositing User: Ms Julia Martin
Date Deposited: 26 Jul 2011 11:05
Last Modified: 07 Dec 2018 09:43
URI: https://archive.lstmed.ac.uk/id/eprint/1921

Statistics

View details

Actions (login required)

Edit Item Edit Item